HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Terence C Tang Selected Research

Hepatocellular Carcinoma (Hepatoma)

11/2010Development of a resistance-like phenotype to sorafenib by human hepatocellular carcinoma cells is reversible and can be delayed by metronomic UFT chemotherapy.
3/2010Impact of metronomic UFT/cyclophosphamide chemotherapy and antiangiogenic drug assessed in a new preclinical model of locally advanced orthotopic hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Terence C Tang Research Topics

Disease

3Neoplasms (Cancer)
07/2012 - 03/2010
2Hepatocellular Carcinoma (Hepatoma)
11/2010 - 03/2010
1Inflammation (Inflammations)
07/2012
1Weight Loss (Weight Reduction)
03/2010

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
07/2012 - 11/2010
2Sorafenib (BAY 43-9006)FDA Link
11/2010 - 03/2010
2Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
11/2010 - 03/2010
1hypusineIBA
07/2012
1Eukaryotic Translation Initiation Factor 5AIBA
07/2012
1Complementary DNA (cDNA)IBA
11/2010
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2010
1Biomarkers (Surrogate Marker)IBA
03/2010

Therapy/Procedure

2Drug Therapy (Chemotherapy)
11/2010 - 03/2010
1Transplantation
11/2010